semaglutide injectable Higher-Dose Injection Proves Mettle in Phase III Trials Ozempic for Weight Loss (Semaglutide)

November 20, 2025: Ozempic Vision Loss and Gastroparesis Lawsuits Consolidated in New Jersey The New Jersey Supreme Court has approved the creation of two multicounty litigations (MCLs) involving Ozempic

Key takeaways: a clinicopathological approach could yield biologically defined subtypes, more precise (biomarker-driven) treatments, and altered insurance rules but it risks excluding people whose distress lacks identifiable biomarkers

The study is being published today in the New England Journal of Medicine and presented at the 61st ERA Congress in Stockholm, Sweden

Glucose-affecting peptides: GH secretagogues can raise blood sugar

Advances in Enzymology and Related Areas of Molecular Biology

The $50 monthly copay is real progress